Gradalis Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Gradalis's estimated revenue is currently $6.2M per year.
- Gradalis's estimated revenue per employee is $144186
- Gradalis's total funding is $40M.
- Gradalis has 43 Employees.
- Gradalis grew their employee count by 43% last year.
- Gradalis currently has 1 job openings.
|Luisa Manning||Vice President - Medical and Scientific Affairs|
|Ernest Bognar||Chief Operating Officer|
|Ruth Chavez||Executive Assistant to President/CEO at Gradalis, Inc.|
|John Nemunaitis||Chief Medical Officer|
|Gladice Wallraven||Vice President, Clinical and Regulatory Operations|
|Walter Chen||Vice President - Finance & Corporate Development|
What Is Gradalis?
We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer. We are developing Vigil®, our proprietary immunotherapy platform in multiple advanced cancer indications.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Family Tree DNA||$5.7M||40||18%||N/A|
Global RNA Drugs Market 2019-2025 is a comprehensive report which provides a detailed overview of the major driver, opportunities, ...
DALLAS, March 04, 2019 (GLOBE NEWSWIRE) -- Gradalis, Inc., a clinical-stage immunotherapy company developing investigational ...
Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Gradalis, miRagen Therapeutics, among others, hold the substantial market ...